The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Direct-to-consumer raw genetic data and third-party interpretation services: more burden than bargain?
Open accessAbstract
The latest response to consumers’ increased demand for accessible genetic health information is the US Food and Drug Administration (FDA)’s recent approval of 23andMe’s direct-to-consumer (DTC) genetic test for the three common BRCA1 and BRCA2 pathogenic variants found in the Ashkenazi Jewish population.1 23andMe and other DTC genetic testing companies officially report out ancestry, trait, and some health information, while also providing consumers with files of their raw genetic data. Up to 62% of consumers use third-party applications to interpret the raw data and health information not included in companies’ reports.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, most DTC companies (including those focused on ancestry or other non-medical traits) also allow customers to download and analyse their raw data, which will often include many thousands of additional rare variants assayed on the SNP-chip that have not undergone stringent quality control and are therefore much more likely to be false positives [15].”
From Assessing the analytical validity of SNP-chips for detecting very rare pathogenic variants: implications for direct-to-consumer genetic testing (2019) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, most direct to consumer companies (including those focused on ancestry or other non-medical traits) also allow customers to download and analyse their raw data, which will often include many thousands of additional rare variants assayed on their SNP chip that have not undergone stringent quality control and are therefore much more likely to be false positives.15”
From Use of SNP chips to detect rare pathogenic variants: retrospective, population based diagnostic evaluation (2021) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“False positive results for rare clinically-actionable variants detected by DTC SNP-chips have been described in practice guidance [13], several case reports [14,15] and two small case series [16,17].”
From Assessing the analytical validity of SNP-chips for detecting very rare pathogenic variants: implications for direct-to-consumer genetic testing (2019) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tandy-Connor, S., Guiltinan, J., Krempely, K., LaDuca, H., Reineke, P., Gutierrez, S., Gray, P., & Tippin Davis, B. (2018) · Genetics in Medicine · doi:10.1038/gim.2018.38 · Cited by 273 · cited 2×
“The recommendation that all results obtained from the raw genetic data of DTC tests need to be clinically confirmed(5) and recent data on false-positive rates indicate that almost half of consumers seeking clinical confirmation of their genetic testing results would be a waste of healthcare dollars.(4)”
Stewart, K. F. J., Wesselius, A., Schreurs, M. A. C., Schols, A. M. W. J., & Zeegers, M. P. (2017) · Journal of Community Genetics · doi:10.1007/s12687-017-0310-z · Cited by 88
Third party interpretation of raw genetic data: an ethical exploration
Badalato, L., Kalokairinou, L., & Borry, P. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2017.126 · Cited by 61
Consumer use and response to online third‐party raw DNA interpretation services
Wang, C., Cahill, T. J., Parlato, A., Wertz, B., Zhong, Q., Cunningham, T. N., & Cummings, J. J. (2017) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.340 · Cited by 45
Cited by
Direct-to-consumer genetic testing
Horton, R., Crawford, G., Freeman, L., Fenwick, A., Wright, C. F., & Lucassen, A. (2019) · BMJ · doi:10.1136/bmj.l5688 · Cited by 151
Recent developments in genetic/genomic medicine
Horton, R. H., & Lucassen, A. (2019) · Clinical Science · doi:10.1042/cs20180436 · Cited by 128
The double-edged sword of digital self-care: Physician perspectives from Northern Germany
Fiske, A., Buyx, A., & Prainsack, B. (2020) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113174 · Cited by 73
Third-Party Genetic Interpretation Tools: A Mixed-Methods Study of Consumer Motivation and Behavior
Nelson, S. C., Bowen, D. J., & Fullerton, S. M. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.05.014 · Cited by 56
MN, W., L, J., JW, H., KS, R., J, T., AT, H., & CF, W. (2021) · BMJ · doi:10.1136/bmj.n214 · Cited by 51
Metadata
- Authors
- Moscarello, T., Murray, B., Reuter, C. M., & Demo, E.
- Affiliations
- Stanford Health Care (US)
- Johns Hopkins University (US)
- Children's Healthcare of Atlanta (US)
- Corresponding author
- Demo, Erin
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 21
- Issue
- 3
- Pages
- 539-541
- ISSN
- 1098-3600 (ISSN-L)
- PMC
- PMC6752274
- OpenAlex
- W2852870703
- Cited by
- 76
- References
- 4
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 1 · 2023: 8 · 2022: 7 · 2021: 9 · 2020: 27 · 2019: 12
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 999 d)
- Locations
- Genetics in Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Social Sciences › Law › Medical and Health Sciences Research
- Keywords
- direct-to-consumer genetic testing, 23andMe, BRCA1, BRCA2, pathogenic variants, Ashkenazi Jewish population, FDA regulation
- MeSH terms
- Direct-To-Consumer Screening and Testing, Adolescent, Adult, Child, Genetic Testing, Humans, Insurance, Health, Reimbursement, Sequence Analysis, DNA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Direct-to-consumer raw genetic data and third-party interpretation services: more burden than bargain? https://app.cochat.ai/papers/10.1038/s41436-018-0097-2
- The paper
- Moscarello, T., Murray, B., Reuter, C. M., & Demo, E. (2019). Direct-to-consumer raw genetic data and third-party interpretation services: more burden than bargain? Genetics in Medicine. https://doi.org/10.1038/s41436-018-0097-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.